Myasthenia gravis (MG) should be classified according to antibody status (acetylcholine, MuSK, LRP4, titin), thymus (hyperplasia, neoplasia, atrophy), age at debut (< or >50 years), symptom ...

Myasthenia gravis (MG) should be subgrouped into early-onset, late-onset, thymoma, ocular, anti-MuSK, anti-LRP4 and antibody-negative MG. MG has a prevalence of 140 per million, and an annual ...

and thymoma should aid in clinical management and decision making for patients with myasthenia gravis (MG). We sought to determine the accuracy of routine radiological examinations in predicting ...

Histopathological examination of the resected tissue confirmed the presence of thymoma. This case illustrates that myasthenia gravis and myositis can spontaneously co-present. Clinicians should ...

An enhanced CT scan of the thymus showed a mass-like soft tissue density in the ... Consensus Guidance for Management (5), the final diagnosis was MG with Myasthenia Gravis Foundation of America (MGFA ...

6 Patients with orthotopic extension of thymomas frequently present with paraneoplastic diseases, especially myasthenia gravis, whereas patients with intrapericardial thymomas primarily present with ...

The National Medical Commission (NMC) has issued Guidelines for the competency-based postgraduate training programme for MCh ...

To determine if myasthenia gravis (MG) with antibodies to MuSK is a distinct subgroup of seronegative MG. Methods: We assayed antibodies to muscle specific tyrosine kinase (MuSK) in 55 MG patients who ...

Despite the history of myasthenia gravis, the prior thymectomy made a thymoma unlikely. Lymphoma and sarcoidosis were also in the differential, but the absence of classic radiological features such as ...

Myasthenia gravis is the prototypical autoimmune disease affecting the postsynaptic acetylcholine receptors at the neuromuscular junction. In about 10% of cases there is an underlying thymoma and ...